Literature DB >> 12559845

Visceral obesity attenuates the effect of the hepatic lipase -514C>T polymorphism on plasma HDL-cholesterol levels in French-Canadian men.

Julie St-Pierre1, Isabelle Miller-Felix, Marie-Eve Paradis, Jean Bergeron, Benoît Lamarche, Jean-Pierre Després, Daniel Gaudet, Marie-Claude Vohl.   

Abstract

UNLABELLED: The dyslipidemic state of visceral obesity is characterized by increased plasma triglyceride (TG) levels, low HDL-cholesterol concentrations and alterations in LDL composition and concentration. A functional, non-coding -514C>T single nucleotide polymorphism (SNP) of the hepatic lipase gene (LIPC) has been related to variation in HDL-cholesterol concentrations.
OBJECTIVES: To investigate the hypotheses that the LIPC -514C>T polymorphism may be associated with a deteriorated lipoprotein-lipid profile and that environmental factor, such as abdominal obesity, alters this association.
METHODS: A total of 235 French-Canadian men from the greater Quebec City area were assigned into three groups on the basis of their LIPC -514C>T SNP, including 149 CC homozygotes, 75 CT heterozygotes, and 11 TT homozygotes.
RESULTS: In the present study, the highest values of BMI, waist circumference, and accumulation of visceral adipose tissue (VAT) were observed among TT homozygotes (p<0.05). After adjustment for age and BMI, TT homozygotes still showed higher plasma apolipoprotein (apo) AI and HDL-TG concentrations than the two other groups (p<0.05). When the two genotype groups (CC vs CT/TT) were further divided on the basis of VAT accumulation using a cut-off point of 130 cm(2) (high vs low) it appears that irrespective of the genotype subjects with low VAT had higher HDL(2)-cholesterol concentrations (p<0.0001). However, lean carriers of the T allele had higher plasma HDL(2)-cholesterol levels than lean CC homozygotes. The beneficial effect of the T allele on plasma HDL(2)-cholesterol levels was abolished in the presence of visceral obesity (VAT>130 cm(2)).
CONCLUSION: In summary, the presence of visceral obesity attenuates the impact of the LIPC -514C>T polymorphism on plasma HDL(2)-cholesterol levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12559845     DOI: 10.1016/s1096-7192(02)00223-8

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  14 in total

1.  A locus on mouse Chromosome 9 (Adip5) affects the relative weight of the gonadal but not retroperitoneal adipose depot.

Authors:  Amanda H McDaniel; Xia Li; Michael G Tordoff; Alexander A Bachmanov; Danielle R Reed
Journal:  Mamm Genome       Date:  2006-11-10       Impact factor: 2.957

2.  Longitudinal changes in triglycerides according to ANGPTL4[E40K] genotype and longitudinal body weight change in the atherosclerosis risk in communities study.

Authors:  Jennifer A Nettleton; Kelly A Volcik; Ellen W Demerath; Eric Boerwinkle; Aaron R Folsom
Journal:  Ann Epidemiol       Date:  2008-09-21       Impact factor: 3.797

Review 3.  The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype.

Authors:  John D Brunzell; Alberto Zambon; Samir S Deeb
Journal:  Biochim Biophys Acta       Date:  2011-09-25

4.  Genetic variation in the hepatic lipase gene and the risk of coronary heart disease among US diabetic men: potential interaction with obesity.

Authors:  C Zhang; R Lopez-Ridaura; E B Rimm; T Li; D J Hunter; F B Hu
Journal:  Diabetologia       Date:  2006-03-29       Impact factor: 10.122

5.  Dietary fat modulation of hepatic lipase variant -514 C/T for lipids: a crossover randomized dietary intervention trial in Caribbean Hispanics.

Authors:  C E Smith; M I Van Rompay; J Mattei; J F Garcia; B Garcia-Bailo; A H Lichtenstein; K L Tucker; J M Ordovás
Journal:  Physiol Genomics       Date:  2017-09-22       Impact factor: 3.107

6.  Medical sequencing at the extremes of human body mass.

Authors:  Nadav Ahituv; Nihan Kavaslar; Wendy Schackwitz; Anna Ustaszewska; Joel Martin; Sybil Hebert; Heather Doelle; Baran Ersoy; Gregory Kryukov; Steffen Schmidt; Nir Yosef; Eytan Ruppin; Roded Sharan; Christian Vaisse; Shamil Sunyaev; Robert Dent; Jonathan Cohen; Ruth McPherson; Len A Pennacchio
Journal:  Am J Hum Genet       Date:  2007-03-05       Impact factor: 11.025

7.  Association between CETP Taq1B and LIPC -514C/T polymorphisms with the serum lipid levels in a group of Tehran's population: a cross sectional study.

Authors:  Mohammad Ali Kashani Farid; Fereidoun Azizi; Mehdi Hedayati; Maryam S Daneshpour; Ahmad Reza Shamshiri; Fereydoun Siassi
Journal:  Lipids Health Dis       Date:  2010-09-07       Impact factor: 3.876

8.  Association of an intronic haplotype of the LIPC gene with hyperalphalipoproteinemia in two independent populations.

Authors:  Hiroshi Iijima; Mitsuru Emi; Manabu Wada; Makoto Daimon; Sayumi Toriyama; Satoru Koyano; Hidenori Sato; Paul N Hopkins; Steven C Hunt; Isao Kubota; Sumio Kawata; Takeo Kato
Journal:  J Hum Genet       Date:  2007-12-27       Impact factor: 3.172

Review 9.  The metabolic syndrome: a crossroad for genotype-phenotype associations in atherosclerosis.

Authors:  Dolores Corella; Jose M Ordovas
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

Review 10.  Quantile-Dependent Expressivity and Gene-Lifestyle Interactions Involving High-Density Lipoprotein Cholesterol.

Authors:  Paul T Williams
Journal:  Lifestyle Genom       Date:  2020-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.